NVST vs REPL · P/E 56, rev $2.51B vs $825.7M cap
Envista Holdings Corp (NVST) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
REPL does not have a complete income-statement cache yet.
NVST currently screens at market cap $3.72B and trailing P/E 55.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the NVST and REPL stock pages for the full models.
Not investment advice.